Identification of PTP1B and α-Glucosidase Inhibitory Serrulatanes from Eremophila spp. by Combined use of Dual High-Resolution PTP1B and α-Glucosidase Inhibition Profiling and HPLC-HRMS-SPE-NMR
- 9 March 2016
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 79 (4) , 1063-1072
Abstract
According to the International Diabetes Federation, type 2 diabetes (T2D) has reached epidemic proportions, affecting more than 382 million people worldwide. Inhibition of protein tyrosine phosphatase-1B (PTP1B) and α-glucosidase is a recognized therapeutic approach for management of T2D and its associated complications. The lack of clinical drugs targeting PTP1B and side effects of the existing α-glucosidase drugs, emphasize the need for new drug leads for these T2D targets. In the present work, dual high-resolution PTP1B and α-glucosidase inhibition profiles of Eremophila gibbosa, E. glabra, and E. aff. drummondii “Kalgoorlie” were used for pinpointing α-glucosidase and/or PTP1B inhibitory constituents directly from the crude extracts. A subsequent targeted high-performance liquid chromatography–high-resolution mass spectrometry–solid-phase extraction–nuclear magnetic resonance spectroscopy (HPLC-HRMS-SPE-NMR) analysis and preparative-scale HPLC isolation led to identification of 21 metabolites from the three species, of which 16 were serrulatane-type diterpenoids (12 new) associated with either α-glucosidase and/or PTP1B inhibition. This is the first report of serrulatane-type diterpenoids as potential α-glucosidase and/or PTP1B inhibitors.Keywords
Funding Information
- University of Copenhagen
- Teknologi og Produktion, Det Frie Forskningsråd (4005-00387)
This publication has 37 references indexed in Scilit:
- Small Molecules as Potent Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors Documented in Patents from 2009 to 2013Mini-Reviews in Medicinal Chemistry, 2015
- Targeting the disordered C terminus of PTP1B with an allosteric inhibitorNature Chemical Biology, 2014
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practiceArchives of Medical Science, 2012
- Discovery of novel PTP1B inhibitors with antihyperglycemic activityActa Pharmacologica Sinica, 2010
- Glycemic Control and Complications in Type 2 Diabetes MellitusThe American Journal of Medicine, 2010
- Global healthcare expenditure on diabetes for 2010 and 2030Diabetes Research and Clinical Practice, 2010
- Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitusBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Postprandial Hyperglycemia and Diabetes ComplicationsDiabetes, 2005
- Protein tyrosine phosphatase 1B inhibitors for diabetesNature Reviews Drug Discovery, 2002
- The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistanceDiabetologia, 1991